Meet us at DCAT week
23-26 March 2026, New York city, Benjamin Suite 2601
Schedule a meeting with our teamWebinar
Discover how advances in peptide synthesis enable sustainable, compliant, scalable manufacturing
Learn more and registerCreating the future in peptides
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usAlzheimer peptide vaccine: Testimonial with Tord Labuda, CEO, Alzinova AB
Learn more about the collaboration
Watch the video hereMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability
19 Jan 2026 - Baar, 19 January 2026 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful closing of its […]
Read morePolyPeptide showcases leadership in sustainable peptide manufacturing with two landmark publications
19 Dec 2025 - The future of peptide manufacturing isn’t just about making more—it’s about making better. Peptide therapeutics are transforming medicine, but traditional production can be resource-intensive. At PolyPeptide, […]
Read more